Cargando…

Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory Breast Cancer

We studied genomic alterations in 19 inflammatory breast cancer (IBC) patients with advanced disease using samples of tissue and paired blood serum or plasma (cell-free DNA, cfDNA) by targeted next generation sequencing (NGS). At diagnosis, the disease was triple negative (TN) in eleven patients (57...

Descripción completa

Detalles Bibliográficos
Autores principales:	Winn, Jennifer S., Hasse, Zachary, Slifker, Michael, Pei, Jianming, Arisi-Fernandez, Sebastian M., Talarchek, Jacqueline N., Obeid, Elias, Baldwin, Donald A., Gong, Yulan, Ross, Eric, Cristofanilli, Massimo, Alpaugh, R. Katherine, Fernandez, Sandra V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072950/ https://www.ncbi.nlm.nih.gov/pubmed/32075053 http://dx.doi.org/10.3390/ijms21041290

Ejemplares similares

Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC)
por: Gong, Yulan, et al.
Publicado: (2021)

Immune phenotype of patients with stage IV metastatic inflammatory breast cancer
por: Fernandez, Sandra V., et al.
Publicado: (2020)

EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells
por: Mu, Zhaomei, et al.
Publicado: (2013)

TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients
por: Fernandez, Sandra V, et al.
Publicado: (2014)

Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer
por: Beck, Tim N., et al.
Publicado: (2019)

Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients
por: Bingham, Catherine, et al.
Publicado: (2017)

Clinical application of RNA sequencing in sarcoma diagnosis: An institutional experience
por: Pei, Jianming, et al.
Publicado: (2019)

Detecting MYB and MYBL1 Fusion Genes in Tracheobronchial Adenoid Cystic Carcinoma by Targeted RNA-Sequencing
por: Pei, Jianming, et al.
Publicado: (2019)

CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome
por: Raghavakaimal, Ashvathi, et al.
Publicado: (2022)

Inflammatory breast cancer (IBC): clues for targeted therapies
por: Fernandez, Sandra V., et al.
Publicado: (2013)

Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas
por: Adams, Daniel L., et al.
Publicado: (2016)

Presence of anaplastic lymphoma kinase in inflammatory breast cancer
por: Robertson, Fredika M, et al.
Publicado: (2013)

NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma
por: Pei, Jianming, et al.
Publicado: (2019)

Advancements in the Treatment of Metastatic Breast Cancer (MBC): The Role of Ixabepilone
por: Cristofanilli, Massimo
Publicado: (2012)

Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing
por: Fernandez, Sandra V., et al.
Publicado: (2023)

Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer
por: Arisi, Maria F., et al.
Publicado: (2022)

Molecular characterization and targeted therapeutic approaches in breast cancer
por: Toss, Angela, et al.
Publicado: (2015)

IMPassionate about immunotherapy for TNBC: from change, to revolution and to cure?
por: Vagia, Elena, et al.
Publicado: (2020)

Evaluating Elacestrant in the Management of ER-Positive, HER2-Negative Advanced Breast Cancer: Evidence to Date
por: Varella, Leticia, et al.
Publicado: (2023)

AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models
por: Mu, Zhaomei, et al.
Publicado: (2014)

A Preclinical Model of Inflammatory Breast Cancer to Study the Involvement of CXCR4 and ACKR3 in the Metastatic Process
por: Wurth, Roberto, et al.
Publicado: (2015)

Dysregulation of miR-1-3p: An Early Event in Colitis-Associated Dysplasia
por: Fragoso, Mariana F., et al.
Publicado: (2022)

Circulating tumor cells in breast cancer: A tool whose time has come of age
por: Swaby, Ramona F, et al.
Publicado: (2011)

Surfactant-assisted one-pot sample preparation for label-free single-cell proteomics
por: Tsai, Chia-Feng, et al.
Publicado: (2021)

The Third International Inflammatory Breast Cancer Conference
por: van Golen, Kenneth L, et al.
Publicado: (2013)

The Landscape of Targeted Therapies in TNBC
por: Vagia, Elena, et al.
Publicado: (2020)

Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC
por: Rypens, Charlotte, et al.
Publicado: (2022)

All trans-retinoic acid (ATRA) induces re-differentiation of early transformed breast epithelial cells
por: ARISI, MARIA F., et al.
Publicado: (2014)

No More Free Drug Samples?
por: Chimonas, Susan, et al.
Publicado: (2009)

Too Many Free Samples
Publicado: (1884)

Variable selection in social-environmental data: sparse regression and tree ensemble machine learning approaches
por: Handorf, Elizabeth, et al.
Publicado: (2020)

Label-Free Direct Detection of miRNAs with Poly-Silicon Nanowire Biosensors
por: He, Jing, et al.
Publicado: (2015)

Constitutively Active Akt1 Cooperates with KRas(G12D) to Accelerate In Vivo Pancreatic Tumor Onset and Progression()()
por: Albury, Toya M., et al.
Publicado: (2015)

Correlates of Positivity Among a Sample of Lebanese University Students
por: Moussa, Sara, et al.
Publicado: (2022)

Wireless, battery-free push-pull microsystem for membrane-free neurochemical sampling in freely moving animals
por: Wu, Guangfu, et al.
Publicado: (2022)

Sample composition alters associations between age and brain structure
por: LeWinn, Kaja Z., et al.
Publicado: (2017)

The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells
por: Salem, Israa, et al.
Publicado: (2016)

Disease Control With FOLFIRI Plus Ziv-aflibercept (zFOLFIRI) Beyond FOLFIRI Plus Bevacizumab: Case Series in Metastatic Colorectal Cancer (mCRC)
por: El-Deiry, Wafik S., et al.
Publicado: (2019)

The High Costs of “Free” Drug Samples
por: Lahey, Tim
Publicado: (2014)

Gain in cellular organization of inflammatory breast cancer: A 3D in vitro model that mimics the in vivo metastasis
por: Morales, Jorge, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_jmgf7tiumd3meuskjug8rl8k1f